Meanwhile, we also observed a reduced frequency of NKG2D+ γδ T cells in patients at the CR stage and the R/R stage compared to the ND-AML stage, suggesting that chemotherapy may be involved. Here, KLRK1 is linked to acute myeloid leukemia.